切换至 "中华医学电子期刊资源库"

中华临床实验室管理电子杂志 ›› 2019, Vol. 07 ›› Issue (03) : 137 -144. doi: 10.3877/cma.j.issn.2095-5820.2019.02.003

所属专题: 专题评论 文献

实验研究

外周血淋巴细胞绝对计数在结直肠癌和食管癌肿瘤进展与治疗前后免疫状态评估的临床应用研究
罗俐梅1, 罗娅1, 蔡宜含1, 冯伟华1, 蔡蓓1,()   
  1. 1. 610041 成都,四川大学华西医院实验医学科 临床检验医学研究中心
  • 收稿日期:2018-08-02 出版日期:2019-08-28
  • 通信作者: 蔡蓓

Clinical study of peripheral T-lymphocyte subsets and NK cells in evaluating the progress of colorectal cancer and esophageal cancer and immune status before and after surgery therapy

Limei Luo1, Ya Luo1, Yihan Cai1, Weihua Feng1, Bei Cai1,()   

  1. 1. Department of Laboratory Medicine, Research Center of Clinical Laboratory Medicine, West China Hospital of Sichuan University, Chengdu 610041, China
  • Received:2018-08-02 Published:2019-08-28
  • Corresponding author: Bei Cai
  • About author:
    Corresponding author: Cai Bei, Email:
引用本文:

罗俐梅, 罗娅, 蔡宜含, 冯伟华, 蔡蓓. 外周血淋巴细胞绝对计数在结直肠癌和食管癌肿瘤进展与治疗前后免疫状态评估的临床应用研究[J]. 中华临床实验室管理电子杂志, 2019, 07(03): 137-144.

Limei Luo, Ya Luo, Yihan Cai, Weihua Feng, Bei Cai. Clinical study of peripheral T-lymphocyte subsets and NK cells in evaluating the progress of colorectal cancer and esophageal cancer and immune status before and after surgery therapy[J]. Chinese Journal of Clinical Laboratory Management(Electronic Edition), 2019, 07(03): 137-144.

目的

通过回顾性分析结直肠癌和食管癌患者手术前后外周血T淋巴细胞和NK细胞数据,探讨免疫细胞绝对计数对于肿瘤患者疾病监测的临床价值。

方法

回顾性分析我院64例结直肠癌和55例食管癌患者手术前后的外周血T淋巴细胞和NK细胞绝对计数与肿瘤病理结果、肿瘤分期的关系,以及动态变化表达结果。

结果

(1)结直肠癌Ⅰ期到Ⅳ期患者术前外周血CD3+、CD3+CD4+、CD3+CD8+T淋巴细胞计数均逐渐增加,其中仅CD3+CD4+、CD3+CD8+T淋巴细胞数目变化具有统计学意义(P<0.05)。术后结直肠癌患者各淋巴细胞亚群计数在TNM分期间无显著性差异。(2)食管癌患者术前各TNM分期间的T淋巴细胞亚群计数未见显著差异(P>0.05);术后食管癌患者CD3+、CD3+CD4+、CD3+CD8+T淋巴细胞计数在Ⅰ期和Ⅲ期均有显著性差异(P<0.05),总体表现为随TNM分期,淋巴细胞计数升高。(3)结直肠癌患者术前外周T淋巴细胞亚群计数具有肿瘤分化程度越高其数目越低的趋势,且伴有淋巴结或远处转移患者的术前T细胞数目增加,NK细胞数目降低,但仅CD3+CD8+T细胞增加有统计学意义(P<0.05);食管癌患者外周T淋巴细胞计数与肿瘤分化程度和肿瘤转移与否均无明显关系。(4)淋巴细胞计数的术前和术后动态分析显示,结直肠癌和食管癌患者外周T细胞亚群和NK细胞数目均表现为术后降低,随后逐渐增高趋势(P<0.05)。

结论

结直肠癌与食管癌外周各淋巴细胞亚群计数在TNM分期、肿瘤分化程度及肿瘤转移与否间的临床表现不同;结直肠癌患者可能因机体高肿瘤负荷及低分化肿瘤促进机体免疫反应性T细胞亚群增殖,而抑制NK细胞增生;手术创伤可导致肿瘤患者机体的T淋巴细胞和NK细胞一过性降低。

Objective

To explore the clinical value of absolute count of peripheral lymphocytes in monitoring immune status of cancer patients with surgery therapy, we retrospectively analyzed the absolute counts of peripheral T-lymphocytes subsets and NK cells before and after surgery in patients with colorectal cancer or esophageal cancer.

Methods

Retrospectively analyzed the absolute counts of T lymphocytes and NK cells and the correlation between lymphocytes counts and tumor progression or pathological staging as well as dynamic characteristics of lymphocyte counts during perioperation in 64 cases of colorectal cancer and 55 cases of esophageal cancer with surgery therapy.

Results

(1) In patients with colorectal cancer, CD3+T lymphocytes, CD3+ CD4+ T lymphocytes and CD3+CD8+ T lymphocytes counts gradually increased from stageⅠto stageⅣ, but only CD3+CD4+ T lymphocytes and CD3+CD8+T lymphocytes increased significantly (P<0.05). No striking difference were found on the absolute counts of lymphocytes from stage Ⅰ to stageⅣafter surgery therapy. (2) In patients with esophageal cancer, the counts of preoperative T lymphocytes subsets in Ⅰ-Ⅳ stage has no significant difference (P>0.05); and the count of postoperative CD3+, CD3+CD4+, CD3+CD8+T lymphocytes gradually increased from stageⅠto stageⅢ (P<0.05). (3) In higher differentiated tumor lower preoperative counts of peripheral T lymphocytes existed in the patients with colorectal cancer (P>0.05). Patients with metastasis have more counts of T lymphocytes subsets and lower count of NK cells than that of patients without metastasis, and only CD3+CD8+T lymphocytes significantly increased (P<0.05). There was no association between peripheral T lymphocytes count and degree of tumor differentiation or tumor metastasis in patients with esophageal cancer. (4) Dynamic analysis of absolute counts of perioperative T lymphocyte subsets and NK cells showed that postoperative T lymphocytes and NK cells firstly strikingly decreased (P<0.05), then increased (P<0.05).

Conclusions

The correlation of peripheral T lymphocytes or NK cells count with TNM staging, degree of tumor differentiation as well as tumor metastasis was not the same between colorectal cancer and esophageal cancer. In patients with colorectal cancer the responsively increasing preoperative T lymphocytes counts and suppression of preoperative NK cells may be caused by high tumor burden and poorly differentiated tumor; surgery trauma could cause transiently decrease of postoperative T lymphocytes and NK cells.

表1 患者基本信息
图1 结直肠癌和食管癌患者手术治疗前后外周血T淋巴细胞亚群或NK细胞绝对计数在肿瘤TNM分期的表达分析
图2 结直肠癌和食管癌患者手术治疗前T淋巴细胞亚群或NK细胞绝对计数表达与肿瘤转移和病理类型的关系分析
表2 结直肠癌和食管癌患者手术前后外周血各淋巴细胞亚群计数比较(±SD)
图3 结直肠癌和食管癌患者手术治疗前后T淋巴细胞亚群或NK细胞计数动态表达分析
1
董颖,杨文君. 消化道恶性肿瘤流行病学特征与发病现状分析[J]. 医学综述, 2014,20(3):429-431.
2
Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle[J]. Immunity, 2013,39(1):1-10.
3
Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual[M]. 7th ed. New York: Springer, 2012.
4
Rice TW, Rusch VW, Apperson-Hansen C, et al. Worldwide esophageal cancer collaboration[J]. Dis Esophagus, 2009,22(1):1-8.
5
梁新强,刘海洲,利基林,等. 乳腺癌患者外周血T淋巴细胞和NK细胞水平分析[J]. 广西医学, 2013,35(2):132-134.
6
张琛琛. 肺腺癌与肺鳞癌肿瘤浸润淋巴细胞的特点分析[D]. 杭州:浙江大学, 2016.
7
Karagöz B, Bilgi O, Gümüs M, et al. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients[J]. Med Oncol, 2010,27(1):29-33.
8
严明基,陈炳光,赵鹏. 外周血T淋巴细胞亚群表达水平对恶性肿瘤病理分期的评估价值[J]. 中国卫生工程学, 2018,17(3):428-429.
9
吴映娥. 恶性肿瘤患者外周血T淋巴细胞亚群的改变及其临床意义[D]. 汕头: 汕头大学, 2007.
10
萧剑军,彭杰文,何洁冰,等. 晚期恶性肿瘤患者CD8及CD28 T淋巴细胞亚群结果分析[J]. 广东医学, 2002,23(S1):12-13.
11
裘宇容,杨春莉,陈炼波等. 原发性肝癌患者CD8+CD28-和CD8+CD28+细胞亚群的分析[J]. 第一军医大学学报, 2002,22(1):72-73.
12
黄庆梅,覃锦耀. CD4+CD25+细胞和CD8+CD28-调节性T细胞在原发性肝癌患者外周血中的水平变化[J]. 检验医学, 2010,25(9):705-707.
13
贾丽,谢晓宝,邱国强,等. 多发性骨髓瘤患者外周血CD4+CD25+和CD8+CD28-调节性T细胞研究[J]. 中国免疫学杂志, 2009,25(11):1033-1037.
14
Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function[J]. Annu Rev Immunol, 2012,30(3):531-564.
15
Shen LS, Wang J, Shen DF, et al. CD4+ CD25+ CD127 low/−, regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression[J]. Clin Immunol, 2009,131(1):109-118.
16
Gomatos IP, Alevizos L, Kalathaki O, et al. Changes in T-lymphocytes′ viability after laparoscopic versus open cholecystectomy[J]. Int Surg, 2015,100(4):696-701.
17
彭聿平,邱一华. 手术应激与免疫抑制[J]. 生理科学进展, 2006,37(1):31-36.
[1] 陈润芝, 杨东梅, 徐慧婷. 信迪利单抗联合索凡替尼后线治疗MSS型BRAF突变的转移性结肠癌:个案报道并文献复习[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 431-435.
[2] 王小娜, 谭微, 李悦, 姜文艳. 预测性护理对结直肠癌根治术患者围手术期生活质量、情绪及并发症的影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 525-529.
[3] 侯超, 潘美辰, 吴文明, 黄兴广, 李翔, 程凌雪, 朱玉轩, 李文波. 早期食管癌及上皮内瘤变内镜黏膜下剥离术后食管狭窄的危险因素[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 383-387.
[4] 单秋洁, 孙立柱, 徐宜全, 王之霞, 徐妍, 马浩, 刘田田. 中老年食管癌患者调强放射治疗期间放射性肺损伤风险模型构建及应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 388-393.
[5] 梁文龙, 曹杰, 黄庆, 林泳, 黄红丽, 杨平, 李冠炜, 胡鹤. 信迪利单抗联合瑞戈非尼治疗晚期结直肠癌的疗效与安全性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 409-413.
[6] 刘代江, 蒋俊艳, 万晓强, 马莎英. 结直肠癌肝转移患者生存状况及预后影响因素分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 284-288.
[7] 苏鹏, 吕会来, 温士旺, 黄超, 张缜, 田子强. 全腔镜下食管癌根治术围手术期呼吸系统并发症发生的危险因素分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 294-298.
[8] 曹旬旬, 费素娟. 食管癌患者肿瘤组织CXCL5和CXCR2的表达与病情和预后的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 299-304.
[9] 杨琬芳, 许晶, 张耀方, 王青, 杨智超, 任方刚, 王宏伟. NK和NKT细胞对急性髓系白血病患者的临床影响[J]. 中华临床医师杂志(电子版), 2023, 17(9): 932-938.
[10] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[11] 王飞飞, 王光林, 孟泽松, 李保坤, 曹龙飞, 张娟, 周超熙, 丁源一, 王贵英. 敲低IMPDH1对结肠癌SW480、HT29细胞生物功能的影响[J]. 中华临床医师杂志(电子版), 2023, 17(08): 884-890.
[12] 孔凡彪, 杨建荣. 肝脏基础疾病与结直肠癌肝转移之间关系的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(07): 818-822.
[13] 王亚丹, 吴静, 黄博洋, 王苗苗, 郭春梅, 宿慧, 王沧海, 王静, 丁鹏鹏, 刘红. 白光内镜下结直肠肿瘤性质预测模型的构建与验证[J]. 中华临床医师杂志(电子版), 2023, 17(06): 655-661.
[14] 陈柯豫, 黄艳齐, 张玲利. 同时性多发早期食管癌及高级别上皮内瘤变的危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(05): 524-528.
[15] 王延召, 牛鹏飞, 丁长民, 高庆坤, 高兆亚, 安柯, 翟志超, 曾庆敏, 黄文生, 雷福明, 顾晋. 结直肠癌致腹壁巨大缺损的一期修补经验(附13例报告)[J]. 中华临床医师杂志(电子版), 2023, 17(05): 557-561.
阅读次数
全文


摘要